Literature DB >> 28719438

Comparative Analysis of Chilblain Lupus Erythematosus and Idiopathic Perniosis: Histopathologic Features and Immunohistochemistry for CD123 and CD30.

Michael L Wang1, May P Chan1,2.   

Abstract

Distinction of chilblain lupus erythematosus (CLE) from idiopathic perniosis (IP) could predict an underlying connective tissue disease; however, histopathologic discrimination of the two is difficult. Increased CD123 plasmacytoid dendritic cells and CD30 lymphocytes have been demonstrated in various forms of cutaneous lupus erythematosus and IP, respectively. To our knowledge, CD123 and CD30 have not been examined in CLE. Our objective was to identify helpful histopathologic and immunohistochemical features in distinguishing CLE and IP. Skin biopsies classified as CLE (n = 20) and IP (n = 39) based on clinicopathologic correlation were collected from 2000 to 2015. Various histopathologic features were examined on hematoxylin and eosin and alcian blue stains. CD123 and CD30 immunostains were performed and characterized. We identified dermal interstitial fibrin exudate (P = 0.0352) and increased dermal mucin (P = 0.0002) as features significantly associated with CLE. Other histopathologic features and CD123 failed to distinguish between groups. CD30 lymphocytes were sparse in all cases. Despite being the largest series of CLE and IP to date, the number of CLE cases in this study remained relatively limited, and some patients in the IP group may have yet to develop diagnostic features of systemic lupus erythematosus. In conclusion, histopathologic distinction between CLE and IP remains challenging. Interstitial fibrin and abundant dermal mucin help favor CLE. The number and distribution of CD123 plasmacytoid dendritic cells and CD30 lymphocytes have no discriminatory role.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28719438     DOI: 10.1097/DAD.0000000000000945

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  10 in total

Review 1.  Diagnostic utility of plasmacytoid dendritic cells in dermatopathology.

Authors:  Tara Bardawil; Samar Khalil; Mazen Kurban; Ossama Abbas
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

2.  A new dermoscopic pattern for chilblain-COVID-19-like skin lesions in adolescents.

Authors:  Gabriella Fabbrocini; Maria Vastarella; Paola Nappa; Maria C Annunziata; Elisa Camela; Vincenzo Greco; Francesca Gaudiello; Maria Alessio; Luca Pierri; Andrea Catzola; Alfredo Guarino
Journal:  JAAD Case Rep       Date:  2020-10-01

3.  Chilblains in immune mediated inflammatory diseases: a review.

Authors:  Shirish Dubey; Nilay Joshi; Olivia Stevenson; Caroline Gordon; John A Reynolds
Journal:  Rheumatology (Oxford)       Date:  2022-04-12       Impact factor: 7.046

4.  A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.

Authors:  M El Hachem; A Diociaiuti; C Concato; R Carsetti; C Carnevale; M Ciofi Degli Atti; L Giovannelli; E Latella; O Porzio; S Rossi; A Stracuzzi; S Zaffina; A Onetti Muda; G Zambruno; R Alaggio
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-02       Impact factor: 9.228

5.  Chilblains in children in the setting of COVID-19 pandemic.

Authors:  David Andina; Lucero Noguera-Morel; Marta Bascuas-Arribas; Jara Gaitero-Tristán; José Antonio Alonso-Cadenas; Silvia Escalada-Pellitero; Ángela Hernández-Martín; Mercedes de la Torre-Espi; Isabel Colmenero; Antonio Torrelo
Journal:  Pediatr Dermatol       Date:  2020-05-22       Impact factor: 1.997

6.  Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient.

Authors:  A G Locatelli; E Robustelli Test; P Vezzoli; A Carugno; E Moggio; L Consonni; A Gianatti; P Sena
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

7.  Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from the authors.

Authors:  L Le Cleach; S Fourati; E Sbidian; M Beylot-Barry
Journal:  Br J Dermatol       Date:  2020-09-24       Impact factor: 11.113

8.  SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.

Authors:  I Colmenero; C Santonja; M Alonso-Riaño; L Noguera-Morel; A Hernández-Martín; D Andina; T Wiesner; J L Rodríguez-Peralto; L Requena; A Torrelo
Journal:  Br J Dermatol       Date:  2020-08-05       Impact factor: 11.113

9.  Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.

Authors:  Christine J Ko; Malini Harigopal; William Damsky; Jeff R Gehlhausen; Marcus Bosenberg; Robert Patrignelli; Jennifer M McNiff
Journal:  J Cutan Pathol       Date:  2020-09-09       Impact factor: 1.458

Review 10.  A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.

Authors:  Athanassios Kolivras; Curtis Thompson; Ievgenia Pastushenko; Marisa Mathieu; Pascal Bruderer; Marine de Vicq; Francesco Feoli; Saadia Harag; Isabelle Meiers; Catherine Olemans; Ursula Sass; Florence Dehavay; Ali Fakih; Xuan-Lan Lam-Hoai; Alice Marneffe; Laura Van De Borne; Valerie Vandersleyen; Bertrand Richert
Journal:  J Cutan Pathol       Date:  2021-08-09       Impact factor: 1.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.